Gradient Investments LLC Exelixis, Inc. Transaction History

Gradient Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	SELL	$17.44 - $23.16 $1,569 - $2,084	-90 Closed	0 $0
Q2 2020 Jul 10, 2020	BUY	$16.46 - $27.42 $1,481 - $2,467	90 New	90 $2,000
Q3 2018 Oct 11, 2018	SELL	$15.87 - $22.4 $6,348 - $8,960	-400 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$18.56 - $22.45 $7,275 - $8,800	392 Added 4900.0%	400 $9,000
Q4 2017 Feb 07, 2018	BUY	$24.23 - $30.93 $193 - $247	8	8 $0

460

246M

1.7M

1.02M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $7.13B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.